Atopic Dermatitis Eczema Clinical Trial
Official title:
Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
Unlike healthy control skin, the skin of patients with atopic dermatitis (AD) is frequently colonized by Staphylococcus aureus (S. aureus), putting these patients at increased risk of S. aureus skin infections. In addition, research in the investigator's lab has shown that these patients have fewer protective antimicrobial Staphylococcal species such as Staphylococcal epidermidis (S. epidermidis) that are known to produce antimicrobial peptides that play a role in protecting the skin from invading pathogens. In this study, the investigator will attempt to decrease S. aureus colonization and increase colonization of protective Staph species in AD patients. First the investigator will capture the bacteria on subjects' skin. Next the investigator will selectively grow the subject's antimicrobial Staphylococcal colonies and place them into a base moisturizer. The moisturizer plus bacteria will be applied to one of the subject's arms for one week. Some subjects will receive placebo, which is the moisturizer alone (without bacteria). The investigator will then swab the arms at specified time points during and after the one week application in order to determine whether the S. aureus abundance was affected by the application of the transplanted bacteria.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05579899 -
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
|
Phase 2 | |
| Terminated |
NCT04085549 -
Effects of a Berry Oil Cream on Atopic Eczema and Skin
|
N/A | |
| Recruiting |
NCT05578482 -
Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis
|
Phase 4 | |
| Completed |
NCT03540043 -
Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
|
Phase 2 | |
| Completed |
NCT03293030 -
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
|
Phase 4 | |
| Completed |
NCT03386032 -
8-Week Atopic Dermatitis (AD) Treatment Study
|
Phase 3 | |
| Completed |
NCT03667014 -
The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
|
Phase 4 | |
| Terminated |
NCT05382819 -
A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
|
Phase 1 | |
| Completed |
NCT04537468 -
Development of a Method to Measure mRNA Levels in Skin Samples
|
N/A | |
| Completed |
NCT03268174 -
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.
|
N/A | |
| Active, not recruiting |
NCT03859986 -
Study in Subjects With Moderate Atopic Dermatitis
|
Phase 2 | |
| Completed |
NCT04800185 -
Characterizing Skin Microbiome Change in Atopic Dermatitis
|
Early Phase 1 | |
| Completed |
NCT06361992 -
Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children
|
Phase 3 | |
| Recruiting |
NCT06024499 -
Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
|
Phase 2 | |
| Recruiting |
NCT03742414 -
Seal, Stopping Eczema and Allergy Study
|
Phase 2 | |
| Not yet recruiting |
NCT06454942 -
Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals
|
N/A | |
| Completed |
NCT03090178 -
Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy
|
N/A | |
| Recruiting |
NCT05935085 -
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).
|
Phase 2 | |
| Recruiting |
NCT03795506 -
TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)
|
N/A | |
| Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|